Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Glenn Coleman Biography and Net Worth

COO of Integra LifeSciences

GLENN G. COLEMAN is Integra’s Executive Vice President and Chief Operating Officer. Mr. Coleman oversees Integra operations and approximately 60% of Integra’s talent force, including clinical, R&D, manufacturing, quality, and business development while also leading our international team. Prior to his promotion in June 2019 to Chief Operating Officer, he acted as the Company’s Chief Financial Officer and was responsible for the finance department, including accounting and financial reporting, budgeting, internal audit, tax, treasury, investor relations, and information technology while also leading our international business. Prior to joining the Company in May 2014 as Corporate Vice President and Chief Financial Officer, he spent 25 years in financial management positions with leading global businesses, including serving as vice president for finance and corporate controller at Curtiss-Wright Corporation. He also worked at Alcatel-Lucent in various finance executive leadership positions. Mr. Coleman began his career at PricewaterhouseCoopers LLP as lead senior manager for a top global account. Mr. Coleman received his B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 25 Provided by Tagnifi.

What is Glenn Coleman's net worth?: The estimated net worth of Glenn Coleman is at least $1.69 million as of November 20th, 2023. Mr. Coleman owns 73,566 shares of Integra LifeSciences stock worth more than $1,686,868 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Coleman may own. Learn More about Glenn Coleman's net worth.
How do I contact Glenn Coleman?: The corporate mailing address for Mr. Coleman and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Glenn Coleman's contact information.
Has Glenn Coleman been buying or selling shares of Integra LifeSciences?: Glenn Coleman has not been actively trading shares of Integra LifeSciences during the last ninety days. Most recently, Glenn Coleman sold 6,268 shares of the business's stock in a transaction on Monday, April 4th. The shares were sold at an average price of $66.04, for a transaction totalling $413,938.72. Following the completion of the sale, the chief operating officer now directly owns 41,288 shares of the company's stock, valued at $2,726,659.52. Learn More on Glenn Coleman's trading history.
Who are Integra LifeSciences' active insiders?: Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.
Are insiders buying or selling shares of Integra LifeSciences?: In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. The most recent insider tranaction occured on May, 23rd when Chairman Stuart Essig bought 52,641 shares worth more than $1,499,742.09. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.
Information on this page was last updated on 5/23/2024.

Glenn Coleman Insider Trading History at Integra LifeSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/4/2022	Sell	6,268	$66.04	$413,938.72	41,288
11/2/2021	Sell	4,275	$74.00	$316,350.00
4/16/2021	Sell	25,658	$71.50	$1,834,547.00	57,714
4/14/2021	Sell	4,002	$70.50	$282,141.00	32,056
4/9/2021	Sell	12,500	$70.00	$875,000.00	48,558
3/29/2021	Sell	15,500	$68.50	$1,061,750.00	36,058
8/11/2020	Sell	5,000	$52.27	$261,350.00	45,894
7/24/2019	Sell	3,500	$57.50	$201,250.00	35,194
6/28/2019	Sell	3,650	$55.00	$200,750.00	25,160
8/9/2018	Sell	8,916	$63.00	$561,708.00	16,795
3/14/2018	Sell	8,769	$56.10	$491,940.90
5/4/2017	Sell	13,865	$45.91	$636,542.15	18,519
5/4/2016	Sell	3,563	$70.62	$251,619.06	12,263

Glenn Coleman Buying and Selling Activity at Integra LifeSciences

Integra LifeSciences Company Overview

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $22.93

$22.32

$22.95

50 Day Range

MA: $19.85

$16.95

$26.70

2 Week Range

Now: $22.93

$16.81

$45.42

Volume

366,165 shs

Average Volume

1,052,990 shs

Market Capitalization

$1.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

This company will win the AI race

From Porter & Company | Ad